Aux côtés de CAPTECH Santé Nutrition, devenez actionnaire d’Hemerion Therapeutics et contribuez à la lutte contre le glioblastome, l’une des tumeurs cérébrales les plus dangereuses 🧠 Les données de survie déjà générées chez les premiers patients traités étant exceptionnelles, Hemerion a désormais débuté une nouvelle étude clinique aux Etats-Unis Découvrez plus d’informations sur Hemerion et sa technologie innovante sur Capital Cell https://lnkd.in/e4fQMZuy
🚀 Join the Hemerion adventure! Since 2020, Hemerion has raised €7 million to develop a revolutionary therapy for glioblastoma, the most aggressive form of brain cancer. The results of our first clinical trials in Europe and the United States are very promising. They position our Pentalafen / Hemerion combination therapy well to become a new standard of care by 2028-29. 🧠💡 In addition to a new round of financing from institutional investors Finovam Gestion Nord France Amorçage CAPTECH Santé Nutrition Bpifrance , we are opening our capital today to the general public via the Capital Cell platform Capital Cell , starting at €1,000. This is a unique opportunity to invest in a fast-growing company 📈, but also to help give new hope to thousands of patients worldwide 🌐. To invest 💶, visit Capital Cell ⤵️ https://lnkd.in/epi4gfbs 🎁Tax deductions of up to 50% of your investment are available. Join our community in the fight against cancer! 🌟 #medtech #healthtech #investment #fundraising #crowdfunding #cancer #startup